2003
Grasty RC, Grey BE, Wolf DC, Lau CS, Rogers JM. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res (Part B) Dev Reprod Toxicol . Dec;68(6):465-71.
Luippold RS, Mundt KA, Austin RP, Liebig E, Panko JP, Crump C, Crump K, Proctor DM . 2003. Lung cancer mortality among chromate workers. 2003. Occup Environ Med . 60:451−457.
Proctor D , Panko J, Liebig E, Mundt K, Buczynski M, Barnhart R, Harris MA , Morgan R, Finley B, and Paustenbach D. 2003. Workplace concentrations of airborne hexavalent chromium for the Painesville, Ohio chromate production plant. Appl Occ Environ Hyg J . 18(6):430-449.
Topics: Hexavalent Chromium
Scott P, Petura J, and Harris MA . 2003. Derivation of a liquid to solid ratio for ASTM method D3987 85 for soils containing chromite ore processing residue using selected unsaturated zone models. Soil Sed Contam . 12(4):443-480.
2002
Grant RL, Rodriguez R, Hofelt CS, and Haws LC . 2002. Shortcomings in USEPA’s approach for predicting risk due to consumption of animal food products impacted by air emissions from hazardous waste combustion facilities: a case study involving phthalates. Human Ecol Risk Assess . 8(5):1137-1154.
Roberts SM, Jordan KE, Warren DA, Britt JK and James RC . 2002. Evaluation of the carcinogenicity of 1,1-Dichloroethylene (Vinylidene Chloride). Regul. Toxicol. Pharmacol . 35:44-55.
Merok, JR, Lansita, JA , Tunstead, JR, Sherley, JL. 2002. “Cosegregation of Chromosomes Containing Immortal DNA Strands in Cells that Cycle with Asymmetric Stem Cell Kinetics,” Cancer Res., 62, 6791-6795.
Hofelt CS, Honeycutt M, McCoy JT, and Haws LC . 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol . 33:60-65.
Strobel HW, Thompson CM , Antonovic L. 2001. Cytochromes P450 in brain: function and significance. Current Drug Metabolism . 2(2), 199–214.
Lea IA , Widgren EE, O’Rand MG. 2002. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20(11–12):1515–1523
View Abstract